Matica Biotechnology, a US subsidiary of CHA Biotech, has appointed Laura Parks as EVP of commercial operations and Heather Sugrue as VP of alliance management to enhance its cell and gene therapy contract manufacturing capabilities.
Matica Biotechnology, a U.S. subsidiary of CHA Biotech, is aiming to capitalize on the growing market of cell and gene therapies by offering a contract manufacturing and development service for the drug makers.
He spends every moment of the day frantically searching for videos of the crowd, hoping to see any last moments of his girlfriend.
For residents seeking support in languages other than Korean, a number of universities and community hubs in Seoul are offering free counseling services.
Matica Biotechnology, a wholly-owned subsidiary of CHA Biotech, celebrated the completion of a cell and gene therapy manufacturing facility in College Station, Texas, Tuesday.
GC Cell and GC bought New Jersey-based BioCentriq for 90 billion won ($73 million), aiming to strengthen their presence in the global gene and cell therapy market.
SK Inc. invested $350 million in the Center for Breakthrough Medicines (CBM), becoming the second largest shareholder of the Philadelphia-based contract and development manufacturing organization (CDMO) specializing in gene and cell therapy.
CHA Biotech signed a contract manufacturing organization (CMO) deal with StemLab to produce the Seongbuk-based venture start-up's neural stem cells, the company said Thursday.
Korean companies are starting to offer workplace counseling and therapy sessions as concerns grow about employees' mental health due to the stress of working while observing social distancing measures during the Covid-19 pandemic.
Basking in the sunlight surrounded by trees and serenaded by chirping birds is an experience almost unique to the great outdoors.
Korea JoongAng Daily Sitemap